Michael Lind
Impact in
- Oncology top 10%
- Metal complexes synthesis and properties
- Cancer Treatment and Pharmacology
- Hematology top 5%
- Erythropoietin and Anemia Treatment
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Ovarian cancer diagnosis and treatment 14
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Hilary Calvert (16 shared papers)Peter M. Wilkinson (4 shared papers)N. Thatcher (3 shared papers)Claude Joseph Ardiet (1 shared paper)Alan V. Boddy (7 shared papers)David R. Newell (5 shared papers)D. Crowther (5 shared papers)N P Bailey (8 shared papers)
- Journals
- British Journal of Cancer (10 papers)Annals of Oncology (5 papers)European Journal of Cancer (4 papers)Lung Cancer (3 papers)Breast Cancer Research (3 papers)
- Partner nations
- United KingdomAustriaUnited States
In The Last Decade
Michael Lind
44 papers receiving 870 citations
Peers
Comparison fields: 5 of 72
- Oncology 279
- Hematology 166
- Reproductive Medicine 115
- Pharmacology 70
- Genetics 63
Countries citing papers authored by Michael Lind
This map shows the geographic impact of Michael Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lind more than expected).
Fields of papers citing papers by Michael Lind
This network shows the impact of papers produced by Michael Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lind. The network helps show where Michael Lind may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 98 | |
| 2 | 1988 | 79 | |
| 3 | 1998 | 78 | |
| 4 | 1999 | 52 | |
| 5 | 1995 | 45 | |
| 6 | 2006 | 45 | |
| 7 | Pharmacokinetics of alkylating agents. | 1993 | 43 |
| 8 | 2004 | 42 | |
| 9 | 1997 | 39 | |
| 10 | 1998 | 38 | |
| 11 | 2002 | 38 | |
| 12 | Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion. | 1995 | 35 |
| 13 | Basic principles in the use of adjuvant therapy. | 1990 | 28 |
| 14 | 1993 | 26 | |
| 15 | 2011 | 26 | |
| 16 | 1992 | 25 | |
| 17 | 1996 | 23 | |
| 18 | 1990 | 20 | |
| 19 | 1999 | 20 | |
| 20 | 1990 | 19 |
About Michael Lind
Michael Lind is a scholar working on Reproductive Medicine, Cancer Research, Oncology, Pharmacology and Hematology, having authored 45 papers that have together received 942 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), Cancer therapeutics and mechanisms (7 papers), Breast Cancer Treatment Studies (7 papers), Pharmacogenetics and Drug Metabolism (4 papers), Erythropoietin and Anemia Treatment (3 papers), Glioma Diagnosis and Treatment (3 papers), Metal complexes synthesis and properties (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). The work is most often cited by research in Oncology (279 citations), Hematology (166 citations), Reproductive Medicine (115 citations), Pharmacology (70 citations) and Genetics (63 citations). Michael Lind has collaborated with scholars based in United Kingdom, Austria and United States. Frequent co-authors include Hilary Calvert, Peter M. Wilkinson, N. Thatcher, Claude Joseph Ardiet, Alan V. Boddy, David R. Newell, D. Crowther, N P Bailey, Lesley Robson and Tim J. Littlewood. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, European Journal of Cancer, Lung Cancer and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.